Top compounds associated with response to EID1


Feature Type Standardized
Nominal ANOVA
mRNA fluvastatin CTRPv2 pan-cancer AAC 0.16 5e-05
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 6e-05
mRNA austocystin d CTRPv2 pan-cancer AAC -0.16 8e-05
mRNA necrosulfonamide CTRPv2 pan-cancer AAC -0.15 0.0003
mRNA lovastatin CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA SGC0946 GDSC1000 pan-cancer AAC 0.13 0.0008
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0009
mRNA TW 37 GDSC1000 pan-cancer AAC 0.12 0.001
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
Download CSV